220 related articles for article (PubMed ID: 16314670)
1. Reconstituted high density lipoprotein enriched with the polyene antibiotic amphotericin B.
Oda MN; Hargreaves PL; Beckstead JA; Redmond KA; van Antwerpen R; Ryan RO
J Lipid Res; 2006 Feb; 47(2):260-7. PubMed ID: 16314670
[TBL] [Abstract][Full Text] [Related]
2. Peptide stabilized amphotericin B nanodisks.
Tufteland M; Pesavento JB; Bermingham RL; Hoeprich PD; Ryan RO
Peptides; 2007 Apr; 28(4):741-6. PubMed ID: 17293004
[TBL] [Abstract][Full Text] [Related]
3. Nanodisks derived from amphotericin B lipid complex.
Tufteland M; Ren G; Ryan RO
J Pharm Sci; 2008 Oct; 97(10):4425-32. PubMed ID: 18271034
[TBL] [Abstract][Full Text] [Related]
4. Polymeric carriers for amphotericin B: in vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice.
Espuelas MS; Legrand P; Campanero MA; Appel M; Chéron M; Gamazo C; Barratt G; Irache JM
J Antimicrob Chemother; 2003 Sep; 52(3):419-27. PubMed ID: 12888593
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of sodium deoxycholate sulfate as a lipid drug carrier to enhance the solubility, stability and safety of an amphotericin B inhalation formulation.
Gangadhar KN; Adhikari K; Srichana T
Int J Pharm; 2014 Aug; 471(1-2):430-8. PubMed ID: 24907597
[TBL] [Abstract][Full Text] [Related]
6. Dectin-1-Targeted Antifungal Liposomes Exhibit Enhanced Efficacy.
Ambati S; Ferarro AR; Kang SE; Lin J; Lin X; Momany M; Lewis ZA; Meagher RB
mSphere; 2019 Feb; 4(1):. PubMed ID: 30760610
[No Abstract] [Full Text] [Related]
7. High purity amphotericin B.
Cleary JD; Chapman SW; Swiatlo E; Kramer R
J Antimicrob Chemother; 2007 Dec; 60(6):1331-40. PubMed ID: 17921178
[TBL] [Abstract][Full Text] [Related]
8. A novel injectable water-soluble amphotericin B-arabinogalactan conjugate.
Falk R; Domb AJ; Polacheck I
Antimicrob Agents Chemother; 1999 Aug; 43(8):1975-81. PubMed ID: 10428922
[TBL] [Abstract][Full Text] [Related]
9. Antifungal activity of amphotericin B cochleates against Candida albicans infection in a mouse model.
Zarif L; Graybill JR; Perlin D; Najvar L; Bocanegra R; Mannino RJ
Antimicrob Agents Chemother; 2000 Jun; 44(6):1463-9. PubMed ID: 10817694
[TBL] [Abstract][Full Text] [Related]
10. In-vivo therapeutic efficacy in experimental murine mycoses of a new formulation of deoxycholate-amphotericin B obtained by mild heating.
Petit C; Chéron M; Joly V; Rodrigues JM; Bolard J; Gaboriau F
J Antimicrob Chemother; 1998 Dec; 42(6):779-85. PubMed ID: 10052902
[TBL] [Abstract][Full Text] [Related]
11. NanoDisk containing super aggregated amphotericin B: a high therapeutic index antifungal formulation with enhanced potency.
Burgess BL; He Y; Baker MM; Luo B; Carroll SF; Forte TM; Oda MN
Int J Nanomedicine; 2013; 8():4733-43. PubMed ID: 24379661
[TBL] [Abstract][Full Text] [Related]
12. Polysorbate Surfactants as Drug Carriers: Tween 20-Amphotericin B Conjugates as Anti-Fungal and Anti-Leishmanial Agents.
Ravichandran V; Kesavan V; Cojean S; Loiseau PM; Jayakrishnan A
Curr Drug Deliv; 2018; 15(7):1028-1037. PubMed ID: 29732967
[TBL] [Abstract][Full Text] [Related]
13. Enhanced antifungal effects of amphotericin B-TPGS-b-(PCL-ran-PGA) nanoparticles in vitro and in vivo.
Tang X; Zhu H; Sun L; Hou W; Cai S; Zhang R; Liu F
Int J Nanomedicine; 2014; 9():5403-13. PubMed ID: 25473279
[TBL] [Abstract][Full Text] [Related]
14. In vivo activity of a novel amphotericin B formulation with synthetic cationic bilayer fragments.
Lincopan N; Mamizuka EM; Carmona-Ribeiro AM
J Antimicrob Chemother; 2003 Sep; 52(3):412-8. PubMed ID: 12917237
[TBL] [Abstract][Full Text] [Related]
15. In vitro antifungal activities of amphotericin B in combination with acteoside, a phenylethanoid glycoside from Colebrookea oppositifolia.
Ali I; Sharma P; Suri KA; Satti NK; Dutt P; Afrin F; Khan IA
J Med Microbiol; 2011 Sep; 60(Pt 9):1326-1336. PubMed ID: 21474610
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and toxicity evaluation of new amphotericin B micelle systems for brain fungal infections.
Moreno-Rodríguez AC; Torrado-Durán S; Molero G; García-Rodríguez JJ; Torrado-Santiago S
Int J Pharm; 2015 Oct; 494(1):17-22. PubMed ID: 26256151
[TBL] [Abstract][Full Text] [Related]
17. Assessment of in vitro antifungal efficacy and in vivo toxicity of Amphotericin B-loaded PLGA and PLGA-PEG blend nanoparticles.
Moraes Moreira Carraro TC; Altmeyer C; Maissar Khalil N; Mara Mainardes R
J Mycol Med; 2017 Dec; 27(4):519-529. PubMed ID: 28797532
[TBL] [Abstract][Full Text] [Related]
18. Spectroscopic studies of amphotericin B solubilized in nanoscale bilayer membranes.
Hargreaves PL; Nguyen TS; Ryan RO
Biochim Biophys Acta; 2006 Jan; 1758(1):38-44. PubMed ID: 16473324
[TBL] [Abstract][Full Text] [Related]
19. Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and
Rossi SA; de Oliveira HC; Agreda-Mellon D; Lucio J; Mendes-Giannini MJS; García-Cambero JP; Zaragoza O
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31988099
[TBL] [Abstract][Full Text] [Related]
20. Preparation, characterization, and evaluation of amphotericin B-loaded MPEG-PCL-g-PEI micelles for local treatment of oral
Zhou L; Zhang P; Chen Z; Cai S; Jing T; Fan H; Mo F; Zhang J; Lin R
Int J Nanomedicine; 2017; 12():4269-4283. PubMed ID: 28652732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
